✦ LIBER ✦

A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation

✍ Scribed by Evangelos Cholongitas; Laura Marelli; Vibhakorn Shusang; Marco Senzolo; Keith Rolles; David Patch; Andrew K. Burroughs

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 139 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20824

No coin nor oath required. For personal study only.

✦ Synopsis

The Model for End-Stage Liver Disease (MELD) score is now used for allocation in liver transplantation (LT) waiting lists, replacing the Child-Turcotte-Pugh (CTP) score. However, there is debate as whether it is superior to CTP score to predict mortality in patients with cirrhosis on the LT waiting list and after LT. We reviewed studies comparing the accuracy of MELD vs. CTP score in transplantation settings. We found that in studies of the LT waiting list (12,532 patients with cirrhosis), only 4 of 11 showed MELD to be superior to CTP in predicting short-term (3-month) mortality. In addition, 2 of 3 studies (n = 1,679) evaluating the changes in MELD score (DeltaMELD) showed that DeltaMELD had better prediction for mortality than the baseline MELD score. The impact of MELD on post-LT mortality was assessed in 15 studies (20,456 patients); only 6 (9,522 patients) evaluated the discriminative ability of MELD score using the concordance (c) statistic (the MELD score had always a c-statistic < 0.70). In 11 studies (19,311 patients), high MELD score indicated poor post-LT mortality for cutoff values of 24-40 points. In re-LT patients, 2 of 4 studies evaluated the discriminative ability of MELD score on post-LT mortality. Finally, several studies have shown that the predictive ability of MELD score increases by adding clinical variables (hepatic encephalopathy, ascites) or laboratory (sodium) parameters. On the basis of the current literature, MELD score does not perform better than the CTP score for patients with cirrhosis on the waiting list and cannot predict post-LT mortality.

📜 SIMILAR VOLUMES

Renal outcomes after liver transplantati

Renal outcomes after liver transplantation in the model for end-stage liver disease era

✍ Pratima Sharma; Kathy Welch; Richard Eikstadt; Jorge A. Marrero; Robert J. Fonta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

The proportion of patients undergoing liver transplantation (LT) with renal insufficiency has significantly increased in the Model for End-Stage Liver Disease (MELD) era. This study was designed to determine the incidence and predictors of post-LT chronic renal failure (CRF) and its effect on patien

Model for end-stage liver disease except

Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system

✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier Chazouillères; Jean-Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific

Liver transplantation cost in the model

Liver transplantation cost in the model for end-stage liver disease era: Looking beyond the transplant admission

✍ Paula Buchanan; Nino Dzebisashvili; Krista L. Lentine; David A. Axelrod; Mark A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

We examined the relationship between the total cost incurred by liver transplantation (LT) recipients and their Model for End-Stage Liver Disease (MELD) score at the time of transplant. We used a novel database linking billing claims from a large private payer with the Organ Procurement and Transpla

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy

✍ Francis Y. Yao; Nathan M. Bass; Nancy L. Ascher; John P. Roberts 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

We examined the impact of the Model for End-Stage Liver Disease (MELD) organ allocation scheme on 44 patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver transplantation (OLT) between February 2002 and January 2003, and compared the outcome with 58 patients listed in the 4 years be

Impact of model for end-stage liver dise

Impact of model for end-stage liver disease (MELD) scoring system on pathological findings at and after liver transplantation

✍ Urmila Khettry; Gissou Azabdaftari; Mary Ann Simpson; Elizabeth A. Pomfret; Jame 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 1 views

The Model for End-Stage Liver Disease (MELD) scoring system, a validated objective liver disease severity scale, was adopted in February 2002 to allocate cadaveric organs for liver transplantation (LT). To improve transplantability before succumbing to advanced disease, patients with low-stage hepat

Critical care of the end-stage liver dis

Critical care of the end-stage liver disease patient awaiting liver transplantation

✍ James Y. Findlay; Oren K. Fix; Catherine Paugam-Burtz; Linda Liu; Puneet Sood; S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

Patients with end-stage liver disease awaiting liver transplantation frequently require intensive care admission and management due to either complications of liver failure or to intercurrent illness, particularly infection. Mortality in such patients is high and the development of an illness necess